We are live on ! Find out more
CPV

Canaan Partners VII Portfolio holdings

AUM $32.3M
1-Year Est. Return 154.97%
This Fund
S&P 500
This Quarter Est. Return
-12.03%
1 Year Est. Return
+154.97%
3 Year Est. Return
-20.69%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$438M
AUM Growth
-$72.9M
Cap. Flow
-$8.23M
Cap. Flow %
-1.88%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
TBRA
Tobira Therapeutics, Inc. Common Stock
TBRA
+$8.23M

Sector Composition

Rank Sector Weight
1 Financials 91.89%
2 Communication Services 3.37%
3 Healthcare 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HAPN
1
Happen Inc
HAPN
$2.08B
$403M 91.89%
6,086,735
– –
MRNS
2
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$20.5M 4.68%
615,350
– –
TLRA
3
DELISTED
Telaria, Inc.
TLRA
$14.8M 3.37%
7,944,522
– –
TBRA
4
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
$230K 0.05%
23,806
-586,628
-96% -$8.23M

Similar funds

A
Aetna Hartford, Connecticut $35.3M AUM 7.55% 1-Year Est. Return
TSP
Tappan Street Partners Chicago, Illinois $35.7M AUM 42.68% 1-Year Est. Return
SAC
SPQ Asia Capital Hong Kong $37.7M AUM 121.14% 1-Year Est. Return
MIGAR
Madison International Global Alpha Realty New York $25.9M AUM
CWM
Concert Wealth Management San Jose, California $24.7M AUM 14.91% 1-Year Est. Return
TCM
Trishield Capital Management New York $40.3M AUM
PVMCV
Polaris Venture Management Co VI Boston, Massachusetts $43.1M AUM 78.12% 1-Year Est. Return
TAM
Target Asset Management Singapore $21.4M AUM 66.83% 1-Year Est. Return

Canaan Partners VII's Q3 2015 Portfolio in Review

As of Q3 2015, Canaan Partners VII held 4 positions worth $438M, down 14% from $511M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2015: portfolio turnover was 0%. Canaan Partners VII opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 92% of assets, up from 88% a quarter earlier, followed by Communication Services and Healthcare.

  • Canaan Partners VII's biggest Q3 2015 reduction was Tobira Therapeutics, Inc. Common Stock, cutting an estimated $8.23M.
  • Canaan Partners VII's ten largest holdings make up 100% of its $438M portfolio in Q3 2015.
  • Canaan Partners VII opened 0 new positions and closed 0 in Q3 2015.
  • Canaan Partners VII's portfolio value fell 14% quarter-over-quarter to $438M.

Based on Canaan Partners VII's 13F filing for Q3 2015, filed 12 Nov 2015.